Moreover, PROK1 was shown to be up-regulated in several types of cancers, such as colorectal cancer, pancreatic cancer, prostate cancer, and ovarian cancer [25,26,27,28,29,30], and was regarded as a poor prognostic marker and survival factor. Here, PROK1 is linked to familial pancreatic carcinoma.